EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ruthenium(II) coordinated with diphenylphosphine and 2-mercaptothiazoline as a selective antiproliferative agent in breast cancer cells

Matheus Reis Santos de Melo, Arthur Barcelos Ribeiro, Marcela de Melo Junqueira, Natália Nascimento Silveira, Raquel Alves Dos Santos, Marcos V Palmeira-Mello, Alzir Azevedo Batista, Denise Crispim Tavares

JBIC Journal of Biological Inorganic Chemistry · 2026

DOI: 10.1007/s00775-026-02178-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JBIC Journal of Biological Inorganic Chemistry, 2026. Verfasst von Matheus Reis Santos de Melo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Mutagenesis, University of Franca, Franca, São Paulo, 14404-600, Brazil. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ruthenium, Breast Neoplasms, Phosphines. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade De Franca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most common malignant neoplasm among women and exhibits high molecular heterogeneity, which directly influences therapeutic response and clinical outcomes. Despite advances in targeted therapies and immunotherapies, tumor recurrence, resistance to conventional treatments, and metastatic potential reinforce the need for more selective and effective pharmacological strategies. In this context, metal complexes, particularly ruthenium(II) derivatives, have attracted considerable attention due to their antitumor profile, greater selectivity, and lower systemic toxicity. Therefore, in the present study, the antineoplastic activity of the RuMTZ complex (2-mercaptothiazoline-di-1,2-bis(diphenylphosphine)ethane-ruthenium(II)) was evaluated in three breast cancer cell lines (MDA-MB-231, MDA-MB-468 and MCF7) and in one non-tumor breast cell line (MCF10A). RuMTZ exhibited greater cytotoxicity against human MDA-MB-468 cells, as demonstrated by cell viability (IC 50 = 1.8 µM) and clonogenic (IC 50 = 0.08 µM) assays, associated with higher selectivity indexes (3.89 and 3.75, respectively). Further studies demonstrated that RuMTZ inhibited cell migration by up to 62.76% and induced cell-cycle arrest in the G0/G1 phase, accompanied by a reduction in the G2/M population. Furthermore, the ruthenium complex induced apoptotic cell death, as observed by flow cytometry and increased levels of cleaved caspase-3 by Western blot. The genotoxic effect of RuMTZ was evidenced by the comet assay and increased γH2AX expression levels. Taken together, these findings demonstrate that RuMTZ exhibits promising antineoplastic activity against breast cancer cells, associated with cell-cycle arrest, induction of DNA damage, and apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsRutheniumBreast NeoplasmsPhosphinesCoordination ComplexesThiazolidinesHumansCell ProliferationFemaleApoptosisDrug Screening Assays, AntitumorCell Line, TumorMDA-MB-231 CellsCell Survival

Stichwörter der Autor:innen

Cleaved caspase-3Mercapto groupsMetallodrugγH2AX

Substanzen

Antineoplastic AgentsRutheniumPhosphinesCoordination ComplexesThiazolidines

Autor:innen und Institutionen

  • Laboratory of Mutagenesis, University of Franca, Franca, São Paulo, 14404-600, Brazil.
  • Laboratory of Mutagenesis, University of Franca, Franca, São Paulo, 14404-600, Brazil. arthur1_@hotmail.com.
  • Laboratory of Genetics and Molecular Biology, University of Franca, Franca, São Paulo, 14404-600, Brazil.
  • Department of Chemistry, Federal University of São Carlos, São Carlos, São Paulo, 13565-905, Brazil.
  • Laboratory of Mutagenesis, University of Franca, Franca, São Paulo, 14404-600, Brazil. denisecrispim2001@yahoo.com.

Förderung

  • Universidade De Franca

Zitieren

APA

de Melo, M. R. S., Ribeiro, A. B., de Melo Junqueira, M., Silveira, N. N., Dos Santos, R. A., Palmeira-Mello, M. V., Batista, A. A., & Tavares, D. C. (2026). Ruthenium(II) coordinated with diphenylphosphine and 2-mercaptothiazoline as a selective antiproliferative agent in breast cancer cells. JBIC Journal of Biological Inorganic Chemistry. https://doi.org/10.1007/s00775-026-02178-5

Vancouver

de Melo MRS, Ribeiro AB, de Melo Junqueira M, Silveira NN, Dos Santos RA, Palmeira-Mello MV, et al. Ruthenium(II) coordinated with diphenylphosphine and 2-mercaptothiazoline as a selective antiproliferative agent in breast cancer cells. JBIC Journal of Biological Inorganic Chemistry. 2026. doi:10.1007/s00775-026-02178-5

BibTeX
@article{deMelo2026,
  author = {de Melo, Matheus Reis Santos and Ribeiro, Arthur Barcelos and de Melo Junqueira, Marcela and Silveira, Natália Nascimento and Dos Santos, Raquel Alves and Palmeira-Mello, Marcos V and Batista, Alzir Azevedo and Tavares, Denise Crispim},
  title = {Ruthenium(II) coordinated with diphenylphosphine and 2-mercaptothiazoline as a selective antiproliferative agent in breast cancer cells},
  journal = {JBIC Journal of Biological Inorganic Chemistry},
  year = {2026},
  doi = {10.1007/s00775-026-02178-5}
}
Kostenlos starten →